The Optimal Hepatocyte Density for a Hollow-Fiber Bioartificial Liver

Annals of Clinical and Laboratory Science

Volumn 34, Issue 1, 2004, Pages 87-93

  Xu, Qingxiang ^a,b   Sun, Xitai ^a   Qui, Yudong ^a   Zhang, Heyuan ^a   Ding, Yitao ^a  

^a NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Acute liver failure; Bioartificial liver; Hepatocytes

Indexed keywords

DIAZEPAM; GLUCOSE 6 PHOSPHATASE; PROTEIN P53; RNA; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL LIVER; BIOARTIFICIAL ORGAN; CELL DENSITY; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; HOLLOW FIBER; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE;

ANIMALS; CELL SURVIVAL; DIAZEPAM; HEPATOCYTES; LEUCINE; LIVER, ARTIFICIAL; RNA; SWINE; SWINE, MINIATURE; TUMOR SUPPRESSOR PROTEIN P53; UREA;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 1442300210     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Shaw BW. More questions than answers. Liver Transplant Surg 1995;1:404-407.
2. Everhart JE, Lombardero M, Detre KM, Zetterman RK, Wiesner RH, Lake JR, Hoofnagle JH. Increased waiting time for liver transplantation results in higher mortality. Transplantation 1997;64:1300-1306.
3. Bilsuttil W, Klintmalm B. Transplantation of the Liver. Saunders, Philadelphia, 1996; pp 861.
4. Emond JC, Whitington PF, Thistlethwaite JR, Alonso EM, Broelsch CE. Reduced-size orthotopic liver transplantation: use in the management of children with chronic liver disease. Hepatology 1989;10:867-872.
5. Stockmann HB, Izermans JN. Prospects for the temporary treatment of acute liver failure. Eur J Gastroenterol Hepatol. 2002;14:195-203.
6. Boudjema K, Bachellier P, Wolf P, Tempe JD, Jaeck D. Auxiliary liver transplantation and bioartificial bridging procedures in treatment of acute liver failure. World J Surg 2002;26:264-274.
7. Sundback CA, Vacanti JP. Alternatives to liver transplantation: from hepatocyte transplantation to tissue-engineered organs. Gastroenterology 2000;228:438-442.
8. Shito M, Kim NH, Baskaran H, Tilles AW, Tompkins RG, Yarmush ML, Toner M. In vitro and in vivo evaluation of albumin synthesis rate of porcine hepatocytes in a flat-plate bioreactor. Artif Organs 2001;25:571-578.
9. Kobayashi N, Okitsu T, Maruyama M, Totsugawa T, Kosaka Y, Hayashi N, Nakaji S, Tanaka N. Development of a cellulose-based microcarrier containing cellular adhesive peptides for a bioartificial liver. Transplant Proc 2003;35:443-444.
10. Gao Y, Xu XP, Hu HZ, Yang JZ. Cultivation of human liver cell lines with microcarriers acting as biological materials of bioartificial liver. World J Gastroenterol 1999; 5:221-224.
11. Xue YL, Zhao SF, Luo Y, Li XJ, Duan ZP, Chen XP, Li WG, Huang XQ, Li YL, Cui X, Zhong DG, Zhang ZY, Huang ZQ. TECA hybrid artificial liver support system in treatment of acute liver failure. World J Gastroenterol 2001;7:826-829.
12. MacDonald JM, Wolfe SP, Roy-Chowdhury I, Kubota H, Reid LM. Effect of flow configuration and membrane characteristics on membrane fouling in a novel multicoaxial hollow-fiber bioartificial liver. Ann NY Acad Sci 2001;944:334-343.
13. Nara M, Hakamada K, Totsuka E, Nozaki T, Takiguchi M, Sasaki M. Efficacy of double filtration plasmapheretic cross-circulation using a high permeability membrane between totally hepatectomized dogs and donor pigs. Transplantation 2001,15:1736-1742.
14. Benoist S, Sarkis R, Chafai N, Barbu V, Honiger J, Lakehal F, Becquemont L, Baudrimont M, Capeau J, Housset C, Nordlinger B. Survival and differentiation of porcine hepatocytes encapsulated by semiautomatic device and allotransplanted in large number without immunosuppression. J Hepatol 2001;35:208-216.
15. Catapano G, Euler M, Gaylor JDS, Gerlach J. Characterization of the distribution of matter in hybrid liver support devices where cells are cultured in a 3-D membrane network or on flat substrata. Int J Artif Organs 2001;24:102-109.
16. Gerlach JC. Development of a hybrid liver support system: a review. Int J Artif Organs 1996;19:645-654.
17. Tilles AW, Berthiaume F, Yarmush ML, Toner M. Critical issues in bioartificial liver development. Technol Health Care 2002;10:177-186.
18. Sauer IM, Obermeyer N, Kardassis D, Theruvath T, Gerlach JC. Development of a hybrid liver support system. Ann NY Acad Sci 2001;944:308-319.
19. Berry MN, Friend DS. High yield preparation of isolated rat liver parenchymal cells. J Cell Biol 1969;43:506-520.
20. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 1976,13:23-28.
21. Roger V, Balladur P, Honiger J, Baudrimont M, Delelo R, Robert A, Calmus Y, Capeau J, Nordlinger B. Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: An experimental study. Ann Surg 1998,228:1-7.
22. Siva JM, Day SH, Nicoll-Griffith DA. Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes. Chem Biol Interact 1999;121:49-63.
23. Tong JZ, De Lagausie P, Furlan V, Bernard O, Alvarez F. Long term culture of adult rat hepatocyte spheroids. Exp Cell Res 1992;200:326-332.
24. Burchell A, Hume R, Burchell B. A new micro-technique for analysis of the human hepatic microsomal glucose-6-phosphatase system. Chin Chim Acta 1988;173:183-192.
25. Morsiani E, Brogli M, Galavotti D, Pazzi P, Puviani AC, Azzena GF. Biologic liver support: optimal cell source and mass. Int J Artif Organs 2002;25:985-993.
26. Liu J, Jauregui HO, Faris RA, Santangini HA, Trenkler DM, Silva PG, Garcia KM. Growth and metabolic activity of immortalized porcine hepatocytes in extracorporeal hollow-fiber liver assist devices. Artif Organs 2001;25: 539-545.
27. Kobayashi N, Noguchi H, Watanabe T, Matsumura T, Totsugawa T, Fujiwara T, Tanaka N. A tightly regulated immortalized human fetal hepatocyte cell line to develop a bioartificial liver. Transplant Proc 2001;33:1948-1949.
28. Hui T, Rozga J, Demetriou AA. Bioartificial liver support. J Hepatobiliary Pancreat Surg 2001;8:1-15.
29. Jasmund I, Langsch A, Simmoteit R, Bader A. Cultivation of primary porcine hepatocytes in an OXY-HFB for use as a bioartificial liver device. Biotechnol Prog 2002;18: 839-846.
30. Morsiani E, Pazzi P, Puviani AC, Brogli M, Valieri L, Gorini P, Scoletta P, Marangoni E, Ragazzi R, Azzena G, Frazzoli E, Di Luca D, Cassai E, Lombardi G, Cavallari A, Faenza S, Pasetto A, Girardis M, Jovine E, Pinna AD. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int J Artif Organs 2002;25:192-202.
31. Rozga J, Holzman MD, Ro MS, Griffin DW, Neuzil DF, Giorgio T, Moscioni AD, Demetriou AA. Development of a hybrid bioartificial liver. Ann Surg 1993;217:502-511.
32. Pahernik SA, Thasler WE, Doser M, Gomez-Lechon MJ, Castell MJ, Planck H, Koebe HG. High density culturing of porcine hepatocytes immobilized on nonwoven polyurethane-based biomatrices. Cells Tissues Organs 2001;168:170-177.
33. Sielaff TD, Nyberg SL, Rollins MD, Hu MY, Amiot B, Lee A, Wu FJ, Hu WS, Cerra FB. Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver. Cell Biol Toxicol 1997;13:357-364.
34. Chen Z, Ding Y, Zhang H. Cryopreservation of suckling pig hepatocytes. Ann Clin Lab Sci 2001;31:391-398.
35. Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann NY Acad Sci 2000; 910:121-137.